Search

Author/Creator Campbell, Kim

11. O9 Reduction of interferon-γ and elevated baseline cytotoxic gene expression in the blood associate with ustekinumab response in SLE. (23rd March 2020)

Authors:
Seridi, Loqmane; Cesaroni, Matteo; Loza, Matt; Schreiter, Jessica; Sweet, Kristen; Campbell, Kim; Lipsky, Peter; Vollenhoven, Ronald van; Hahn, Bevra H; Tsokos, George C; Chevrier, Marc; Rose, Shawn; Baribaud, Frédéric; Jordan, Jarrat
Journal:
Lupus science & medicine
Issue:
Volume 7(2020)Supplement 1
Page Start:
A12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. OP0278 BIOMARKER PROFILING REVEALS NOVEL MECHANISTIC INSIGHTS INTO USTEKINUMAB THERAPEUTIC RESPONSES IN SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019)

Authors:
Cesaroni, Matteo; Seridi, Loqmane; Jordan, Jarrat; Sweet, Kristen; Keying, MA; Franks, Carol; Schreiter, Jessica; Lipsky, Peter; Vollenhoven, Ronald van; Hahn, Bevra H.; Rose, Shawn; Baribaud, Frederic; Loza, Matthew J; Campbell, Kim; Tsokos, George
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Reply: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia. (3rd June 2018)

Authors:
McBride, Ali; Campbell, Kim; Bikkina, Mohan; MacDonald, Karen; Abraham, Ivo; Balu, Sanjeev
Journal:
Journal of medical economics
Issue:
Volume 21:Number 6(2018)
Page Start:
606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Responsiveness of Serum C‐Reactive Protein, Interleukin‐17A, and Interleukin‐17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double‐Blind, Placebo‐Controlled Trials. Issue 10 (3rd September 2019)

Authors:
Siebert, Stefan; Sweet, Kristen; Dasgupta, Bidisha; Campbell, Kim; McInnes, Iain B.; Loza, Matthew J.
Journal:
Arthritis & rheumatology
Issue:
Volume 71:Issue 10(2019)
Page Start:
1660
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus. Issue 3 (1st February 2021)

Authors:
Cesaroni, Matteo; Seridi, Loqmane; Loza, Matthew J.; Schreiter, Jessica; Sweet, Kristen; Franks, Carol; Ma, Keying; Orillion, Ashley; Campbell, Kim; M. Gordon, Robert; Branigan, Patrick; Lipsky, Peter; van Vollenhoven, Ronald; Hahn, Bevra H.; Tsokos, George C.; Chevrier, Marc; Rose, Shawn; Bariba...
Journal:
Arthritis & rheumatology
Issue:
Volume 73:Issue 3(2021)
Page Start:
472
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis. Issue 2 (29th December 2018)

Authors:
Deodhar, Atul; Gensler, Lianne S.; Sieper, Joachim; Clark, Michael; Calderon, Cesar; Wang, Yuhua; Zhou, Yiying; Leu, Jocelyn H.; Campbell, Kim; Sweet, Kristen; Harrison, Diane D.; Hsia, Elizabeth C.; van der Heijde, Désirée
Other Names:
Ariel Frederico investigator.; Asnal Cecilia Adma investigator.; Berman Alberto investigator.; Citera Gustavo investigator.; Rodriguez Graciela investigator.; Savio Veronica Gabriela investigator.; Bird Paul investigator.; Griffiths Hedley investigator.; Nicholls David investigator.; Rischmueller...
Journal:
Arthritis & rheumatology
Issue:
Volume 71:Issue 2(2019)
Page Start:
258
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗